INSEAD Day 4 - 728x90

Mashreq Q1 profit rises

Total revenue increased 10% year-on-year.

TECOM profit climbs

High occupancy across assets boosts earnings.

Emirates Stallions Q1 revenue up 11%

The rise helped by strong demand in real estate

ADNOC Distribution 2025 dividend $700m

The company had reported EBITDA of $1.17 bn in 2025.

Empower okays $119.1m H2 2025 dividend

The dividend is equivalent to 43.75% of paid-up capital.

Dubai international pharma exhibition generates deals worth $1.38 bn

DUPHAT 2022 attracted more than 22,000 participants from 82 countries. Pic WAM.
  • The largest of its kind in the region, DUPHAT 2022 was held at the Dubai World Trade Centre and featured the participation of a number of doctors and pharmacists.
  • The event attracted more than 22,000 visitors and participants from 82 countries and featured 140 speakers who shared their insights at 112 scientific sessions.

The 27th edition of the Dubai International Pharmaceutical & Technologies Conference and Exhibition (DUPHAT 2022) has generated direct and indirect business deals worth AED5.1 billion ($1.38 billion).

The largest of its kind in the region, DUPHAT 2022 was held at the Dubai World Trade Centre and featured the participation of a number of doctors, pharmacists, as well as regional and international speakers.

The event also featured prominent pharmaceutical companies from across the world that showcased the latest technological advancements in the sector.

Dr. Abdul Salam Al Madani, Executive Chairman of DUPHAT and Chairman of INDEX Holding, said the deals at DUPHAT reflected the UAE’s role in “leading economic recovery and its ability to provide opportunities for growth across different sectors”.

“This year, we have given participants the opportunity to meet new clients, suppliers, and manufacturers in the industry to build partnerships and strong long-term business networks,” he said.

Organised over an area of 30,000 square meters, the event attracted more than 22,000 visitors and participants from 82 countries. The event featured 140 speakers who shared their insights at 112 scientific sessions, which focused on key issues and developments in the pharmaceutical industry. Additionally, the event saw 330 presentations and various workshops hosted to discuss the latest scientific research in the pharmaceutical sector.